Robert P. Mauch Sells 5,097 Shares of Cencora (NYSE:COR) Stock

Key Points

• Cencora CEO Robert Mauch sold 5,097 shares of the company's stock on September 18th for a total of approximately $1.48 million, representing an 11.49% decrease in his position.
• The company's stock price recently declined by 0.4%, trading at $288.98, with a current market cap of $56.03 billion.
• Cencora announced a quarterly dividend of $0.55 per share, which equates to an annualized yield of 0.8%.

Cencora, Inc. (NYSE:COR - Get Free Report) CEO Robert P. Mauch sold 5,097 shares of the business's stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $290.00, for a total value of $1,478,130.00. Following the sale, the chief executive officer owned 39,274 shares in the company, valued at approximately $11,389,460. The trade was a 11.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Cencora Price Performance

COR traded up $10.92 during trading on Tuesday, reaching $299.71. 492,728 shares of the stock were exchanged, compared to its average volume of 1,577,788. The business's 50 day moving average price is $292.26 and its two-hundred day moving average price is $287.53. The company has a debt-to-equity ratio of 3.64, a current ratio of 0.90 and a quick ratio of 0.53. The company has a market capitalization of $58.11 billion, a price-to-earnings ratio of 30.80, a P/E/G ratio of 1.48 and a beta of 0.62. Cencora, Inc. has a 1 year low of $218.65 and a 1 year high of $309.35.

Cencora (NYSE:COR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $4.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.79 by $0.21. Cencora had a return on equity of 267.36% and a net margin of 0.60%.The business had revenue of $80.66 billion for the quarter, compared to the consensus estimate of $80.34 billion. During the same period in the prior year, the business earned $3.34 earnings per share. The business's revenue was up 8.7% on a year-over-year basis. As a group, equities research analysts anticipate that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 3rd. Shareholders of record on Friday, August 15th were paid a dividend of $0.55 per share. The ex-dividend date was Friday, August 15th. This represents a $2.20 annualized dividend and a yield of 0.7%. Cencora's dividend payout ratio is currently 22.63%.

Wall Street Analyst Weigh In

COR has been the subject of several research analyst reports. Jefferies Financial Group upped their price target on Cencora from $275.00 to $300.00 and gave the stock a "hold" rating in a research note on Monday, June 30th. Wells Fargo & Company increased their target price on Cencora from $337.00 to $354.00 and gave the company an "overweight" rating in a research note on Wednesday, August 13th. Finally, Morgan Stanley set a $330.00 target price on Cencora and gave the company an "equal weight" rating in a research note on Wednesday, July 16th. Nine research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $311.25.

Institutional Trading of Cencora

Large investors have recently added to or reduced their stakes in the business. Atlantic Edge Private Wealth Management LLC increased its position in shares of Cencora by 70.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company's stock valued at $25,000 after purchasing an additional 35 shares during the period. Cornerstone Planning Group LLC boosted its position in shares of Cencora by 106.7% in the first quarter. Cornerstone Planning Group LLC now owns 93 shares of the company's stock worth $26,000 after buying an additional 48 shares during the period. Hoey Investments Inc. acquired a new stake in shares of Cencora in the first quarter worth $28,000. Costello Asset Management INC acquired a new stake in shares of Cencora in the first quarter worth $28,000. Finally, Vermillion & White Wealth Management Group LLC boosted its position in shares of Cencora by 69.4% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company's stock worth $31,000 after buying an additional 43 shares during the period. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.